| scholarly article | Q13442814 |
| P50 | author | Florian Seeger | Q114320863 |
| Cornel Badorff | Q117267669 | ||
| Stefanie Dimmeler | Q110856 | ||
| Andreas Zeiher | Q501318 | ||
| P433 | issue | 7 | |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 645-654 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation | |
| P478 | volume | 97 |
| Q41887552 | A rare human sequence variant reveals myocardin autoinhibition |
| Q33936321 | A screen for regulators of survival of motor neuron protein levels |
| Q33935805 | Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes |
| Q37156982 | CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation |
| Q35643799 | Cardiac hypertrophy is positively regulated by MicroRNA miR-23a. |
| Q38480325 | Cellular FLICE-Inhibitory Protein Protects Against Cardiac Remodeling Induced by Angiotensin II in Mice |
| Q37174611 | Constitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3α during aging and hemodynamic pressure overload |
| Q37789112 | Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies |
| Q37081700 | Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload |
| Q28575707 | Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase |
| Q24304242 | Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling |
| Q30472813 | GSK-3: Functional Insights from Cell Biology and Animal Models |
| Q40963450 | GSK3 as a Sensor Determining Cell Fate in the Brain |
| Q36497030 | Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis |
| Q37594217 | IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling |
| Q21296855 | Identification of candidate genes potentially relevant to chamber-specific remodeling in postnatal ventricular myocardium |
| Q42180878 | In search of novel targets for heart disease: myocardin and myocardin-related transcriptional cofactors |
| Q36908289 | Myocardial AKT: the omnipresent nexus |
| Q38368573 | Myocardin in biology and disease |
| Q43232684 | NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways |
| Q38816280 | Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders |
| Q42714302 | Partnering up for cardiac hypertrophy. |
| Q39171320 | Phosphorylation acts positively and negatively to regulate MRTF-A subcellular localisation and activity |
| Q33553293 | Phosphorylation of myocardin by extracellular signal-regulated kinase |
| Q38858325 | Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells |
| Q38849785 | Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation |
| Q38669134 | Regulation of cardiac myocyte cell death and differentiation by myocardin. |
| Q35925825 | STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin |
| Q36959935 | Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization |
| Q37890184 | Signaling mechanisms that regulate smooth muscle cell differentiation |
| Q36887547 | Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface |
| Q43442947 | Smooth muscle phenotypic diversity is mediated through alterations in myocardin gene splicing |
| Q34058563 | Targeted gene-silencing reveals the functional significance of myocardin signaling in the failing heart |
| Q37210931 | The GSK-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling |
| Q54977618 | The Role of Endoplasmic Reticulum Stress-Glycogen Synthase Kinase-3 Signaling in Atherogenesis. |
| Q35001234 | What Are the bona fide GSK3 Substrates? |
| Q24598242 | miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy |
| Q43062306 | {beta}-Catenin regulates airway smooth muscle contraction |
| Q39454012 | β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition |
Search more.